Merger & Acquisition

A West Coast footprint and professional focus: Evoke's CEO on its Giant acquisition

A West Coast footprint and professional focus: Evoke's CEO on its Giant acquisition

By

Reid Connolly talks the benefits of buying San Francisco-based firm Giant.

Publicis Health acquires Payer Sciences

Publicis Health acquires Payer Sciences

By

Payer Sciences is a health marketing agency that uses data and analytics to gather insights about payer behavior.

Private-equity funds dominate marcomms M&A

Private-equity funds dominate marcomms M&A

By

Nearly a quarter (22%) of all marcomms M&A deals involved private-equity funds — double the 11% seen in the last two quarters of 2017.

Agency M&As up 126% globally, with U.S. leading the way

Agency M&As up 126% globally, with U.S. leading the way

U.S. deals through the end of March increased 366% compared with last year.

Dohmen Life Science acquired by Water Street Healthcare, JLL Partners

Dohmen Life Science acquired by Water Street Healthcare, JLL Partners

By

Dohmen will continue to operate under its brand and retain its leadership team.

New entrants shake up agency M&A market as ad groups are 'distracted' by restructuring

New entrants shake up agency M&A market as ad groups are 'distracted' by restructuring

The agency M&A market is changing as the big ad groups have been "distracted" by internal restructuring and new acquirers are emerging.

Stagwell's Penn says digital marketing agencies are 'undervalued' as he eyes more M&A

Stagwell's Penn says digital marketing agencies are 'undervalued' as he eyes more M&A

By

The founder of Stagwell has claimed digital marketing agencies are undervalued because investors still fail to appreciate how much digital communications and e-commerce are going to transform the economy.

Five things for pharma marketers to know: Tuesday, January 9, 2018

Five things for pharma marketers to know: Tuesday, January 9, 2018

By

Shire considers splitting into two units; New Jersey finalizes physician-pharma gift limit; more biotech M&As expected in 2018

Five things for pharma marketers to know: Friday, January 5, 2018

Five things for pharma marketers to know: Friday, January 5, 2018

By

Takeda announces deals worth more than $1 billion; biotech and pharma investments reached $10.5 billion in 2017; prescriptions for nerve pain on the rise

Five things for pharma marketers to know: Monday, December 18, 2017

Five things for pharma marketers to know: Monday, December 18, 2017

By

CVS/Aetna deal will affect healthcare benefits; lawmakers pressure DEA to curb painkiller supply; Allergan and Richter's Vraylar sees positive results for bipolar depression

CVS/Aetna Moves Healthcare M&A Beyond Cost and into Disruption

CVS/Aetna Moves Healthcare M&A Beyond Cost and into Disruption

This time around the M&A moves will be much bigger in scope, promising to reconfigure the complex and fragile healthcare payer/provider/patient ecosystem.

 Five things for pharma marketers to know: Thursday, December 7, 2017

Five things for pharma marketers to know: Thursday, December 7, 2017

By

UnitedHealth Group to buy DaVita primary care unit for $4.9 billion; Roche drug combo doubles lung-cancer survival in trial; study: FDA programs expedite drug approval

Five things for pharma marketers to know: Thursday, July 27, 2017

Five things for pharma marketers to know: Thursday, July 27, 2017

By

Generic drugmakers reportedly seeking deals; GSK to refocus R&D; Merck and AstraZeneca to test combo cancer drug

Five things for pharma marketers to know: Thursday, July 20, 2017

Five things for pharma marketers to know: Thursday, July 20, 2017

By

About 4.4 billion prescriptions filled in the U.S. in 2016; Sanofi and Ablynx reach I-O deal; biotech M&A slows in H1

Five things for pharma marketers to know: Thursday, June 29, 2017

Five things for pharma marketers to know: Thursday, June 29, 2017

By

Walgreens ends merger with Rite Aid; Biogen hires former Novartis exec as SVP of corporate affairs; FDA takes new measures to drive drug pricing competition

Some brands thought to shift online ad dollars, creating uncertainty for WebMD

Some brands thought to shift online ad dollars, creating uncertainty for WebMD

By

This and other changes in the market have created demand for new offerings, like mobile-friendly sites, video, and patient communities.

WebMD considers sale or merger

WebMD considers sale or merger

By

Drugmakers are becoming much more cautious with their budgets, WebMD executives said.

Five things for pharma marketers to know: Wednesday, February 15, 2017

Five things for pharma marketers to know: Wednesday, February 15, 2017

By

Pharma execs raise concerns about Trump's plans for the FDA; Merck ends study of experimental Alzheimer's drug; Amgen seeks new indication for Blincyto

Five things for pharma marketers to know: Wednesday, August 3, 2016

Five things for pharma marketers to know: Wednesday, August 3, 2016

By

Merck and Allergan reportedly vying to buy Biogen; drugmakers fight California measure capping drug prices; few seniors use the web to look for health info

Five things for pharma marketers to know: Thursday, April 7, 2016

Five things for pharma marketers to know: Thursday, April 7, 2016

By

Pfizer considers its options, post-Allergan deal; Allergan CEO says Treasury's rule-change was 'un-American;' IBM partners with Pfizer to study Parkinson's

WPP acquires CMI, retains minority stake in Compas

WPP acquires CMI, retains minority stake in Compas

By

WPP's acquisition of CMI, a significant player in the healthcare media-planning space, will likely bolster the services it provides to pharma clients.

Sudler & Hennessey acquires West Coast digital marketing firm

Sudler & Hennessey acquires West Coast digital marketing firm

By

Viscira, a digital marketing agency, works with GlaxoSmithKline, Merck, and Genentech, among other life-sciences companies.

Is This the End of Agency Diversification?

Is This the End of Agency Diversification?

By

DTC and OTC/wellness can borrow from mainstream consumer shops. Professional marketing may pose a tougher sell.

Five things for pharma marketers to know: Wednesday, October 14, 2015

Five things for pharma marketers to know: Wednesday, October 14, 2015

By

J&J should pursue tuck-in deals; Lilly offers online college course about drug development; Clinton and Sanders identify drugmakers as political enemies